Vídeos del Professor Gerald Carr-White
Cardiomyopathy Conference 2020 - Commonly Prescribed Medication - Dr Gerry Carr-White
Description:
Dr Gerry Carr-White - Vice President of Cardiomyopathy UK, introduces some of the medication available for people affected by cardiomyopathy. Your questions: 38:55 - Can my beta-blocker restrict my ability to exercise? 39:48 - Can the timings of taking medication make a difference to the effect of the drugs? 40:38 - When will Dapagliflozin be available for heart failure patients and who will qualify? 41:20 - Is Mavacamten available on the NHS? 41:43 - I have DCM and I’ve been taking Ramipril for 10 years at a low dose. I have read that there’s a report saying long term use can contribute to developing lung cancer – what is your view on this? 42:05 - Myokardia and Cytokenetics both seem to be in late stage development drugs for HCM and DCM. Do you approximate time it may take before these get released to market if approved? And are there any other promising therapies in development? 42:34 - Are there any alternatives ACE Inhibitors to Ramipril? This is a recording of a live presentation at the Cardiomyopathy Conference 2020, hosted by Cardiomyopathy UK. We need your support to make up for lost income due to the impact of the Covid-19 pandemic on our fundraising, as we may lose as much as £180,000 or 20% of our income by the end of this year. Your donations help us to deliver events like the Cardiomyopathy Conference, reaching more people than ever before. If you can, please donate at https://www.cardiomyopathy.org/support-us-donate/regular-donations If any content infringes on copyright, we will remove it, just let us know. Please note, we do not own the presentations, only the recordings taken from our Conference. www.cardiomyopathy.org